Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 1.50 is in line with its 5-year average of 1.48, near the low end of its 5-year range (1.15–3.66).
As of the fiscal period ended Tuesday, June 30, 2026. 3.94% below its 12-month average of 1.56.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.50.
QUICK RATIO (ACID-TEST)
1.50
QUICK RATIO (ACID-TEST) AVG TTM
1.56
QUICK RATIO (ACID-TEST) AVG 3Y
1.53
QUICK RATIO (ACID-TEST) AVG 5Y
1.48
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-3.94%
CURRENT VS 3Y AVG
-1.95%
CURRENT VS 5Y AVG
+1.38%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.99
median of 506 covered companies
CURRENT VS SECTOR MEDIAN
-49.79%
vs the sector median at left
Clover Health Investments, Corp.
Market Cap
$2.43B
Quick Ratio (Acid-Test)
1.50
TTM Avg
1.56
3Y Avg
1.53
5Y Avg
1.48
Market Cap
$2.43B
Quick Ratio (Acid-Test)
24.14
TTM Avg
21.55
3Y Avg
17.24
5Y Avg
12.65
Market Cap
$2.36B
Quick Ratio (Acid-Test)
3.81
TTM Avg
3.32
3Y Avg
2.77
5Y Avg
2.91
Market Cap
$2.51B
Quick Ratio (Acid-Test)
5.03
TTM Avg
4.66
3Y Avg
4.92
5Y Avg
7.11
Market Cap
$2.31B
Quick Ratio (Acid-Test)
3.45
TTM Avg
3.42
3Y Avg
3.65
5Y Avg
3.62
Market Cap
$2.76B
Quick Ratio (Acid-Test)
14.57
TTM Avg
8.96
3Y Avg
7.17
5Y Avg
6.28
Market Cap
$2.69B
Quick Ratio (Acid-Test)
10.23
TTM Avg
3.96
3Y Avg
3.96
5Y Avg
3.96
Market Cap
$2.17B
Quick Ratio (Acid-Test)
11.82
TTM Avg
14.70
3Y Avg
15.08
5Y Avg
16.52
Market Cap
$2.68B
Quick Ratio (Acid-Test)
1.56
TTM Avg
1.27
3Y Avg
1.12
5Y Avg
1.27
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Clover Health Investments, Corp. (CLOV) | $2.43B | 1.50 | 1.56 | 1.53 | 1.48 |
| Disc Medicine, Inc. (IRON)vs › | $2.43B | 24.14 | 21.55 | 17.24 | 12.65 |
| ADMA Biologics, Inc. (ADMA)vs › | $2.36B | 3.81 | 3.32 | 2.77 | 2.91 |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.51B | 5.03 | 4.66 | 4.92 | 7.11 |
| Harmony Biosciences Holdings, Inc. (HRMY)vs › | $2.31B | 3.45 | 3.42 | 3.65 | 3.62 |
| Beam Therapeutics Inc. (BEAM)vs › | $2.76B | 14.57 | 8.96 | 7.17 | 6.28 |
| Alamar Biosciences, Inc. (ALMR)vs › | $2.69B | 10.23 | 3.96 | 3.96 | 3.96 |
| Celldex Therapeutics, Inc. (CLDX)vs › | $2.17B | 11.82 | 14.70 | 15.08 | 16.52 |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.68B | 1.56 | 1.27 | 1.12 | 1.27 |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.68B | 1.16 | 1.32 | 1.06 | 0.97 |
Quick Ratio
1.50
Excludes inventory
Current Ratio
1.50
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 1.50 |
| 2026-03-31 | 1.33 |
| 2025-12-31 | 1.47 |
| 2025-09-30 | 1.71 |
| 2025-06-30 | 1.80 |
| 2025-03-31 | 1.54 |
| 2024-12-31 | 1.61 |
| 2024-09-30 | 1.55 |
| 2024-06-30 | 1.69 |
| 2024-03-31 | 1.55 |
| 2023-12-31 | 1.64 |
| 2023-09-30 | 1.27 |
| 2023-06-30 | 1.24 |
| 2023-03-31 | 1.15 |
| 2022-12-31 | 1.45 |
| 2022-09-30 | 1.29 |
| 2022-06-30 | 1.16 |
| 2022-03-31 | 1.16 |
| 2021-12-31 | 2.02 |
| 2021-09-30 | 2.43 |
| 2021-06-30 | 3.66 |
| 2021-03-31 | 4.68 |
| 2020-12-31 | 1.16 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 0.00 |
| 2019-09-30 | 0.00 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 0.00 |
